Literature DB >> 20664519

Probiotics and the gut microbiota in intestinal health and disease.

Mélanie G Gareau1, Philip M Sherman, W Allan Walker.   

Abstract

The use of probiotics is increasing in popularity for both the prevention and treatment of a variety of diseases. While a growing number of well-conducted, prospective, randomized, controlled, clinical trials are emerging and investigations of underlying mechanisms of action are being undertaken, questions remain with respect to the specific immune and physiological effects of probiotics in health and disease. This Review considers recent advances in clinical trials of probiotics for intestinal disorders in both adult and pediatric populations. An overview of recent in vitro and in vivo research related to potential mechanisms of action of various probiotic formulations is also considered.

Entities:  

Mesh：

Year:  2010        PMID： 20664519      PMCID： PMC4748966          DOI： 10.1038/nrgastro.2010.117

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  131 in total

Review 1.  Role of probiotic therapy in IBD.

Authors:  Kim Isaacs; Hans Herfarth
Journal:  Inflamm Bowel Dis       Date:  2008-11       Impact factor: 5.325

2.  Efficacy of probiotic use in acute diarrhea in children: a meta-analysis.

Authors:  Jeannie S Huang; Athos Bousvaros; John W Lee; Angela Diaz; Emily J Davidson
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

3.  Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.

Authors:  Christel Rousseaux; Xavier Thuru; Agathe Gelot; Nicolas Barnich; Christel Neut; Laurent Dubuquoy; Caroline Dubuquoy; Emilie Merour; Karen Geboes; Mathias Chamaillard; Arthur Ouwehand; Greg Leyer; Didier Carcano; Jean-Frédéric Colombel; Denis Ardid; Pierre Desreumaux
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

Review 4.  The core gut microbiome, energy balance and obesity.

Authors:  Peter J Turnbaugh; Jeffrey I Gordon
Journal:  J Physiol       Date:  2009-06-02       Impact factor: 5.182

5.  Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus.

Authors:  Zaed Z R Hamady; Nigel Scott; Mark D Farrar; J Peter A Lodge; Keith T Holland; Terence Whitehead; Simon R Carding
Journal:  Gut       Date:  2009-09-07       Impact factor: 23.059

6.  Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses.

Authors:  Siobhain M O'Mahony; Julian R Marchesi; Paul Scully; Caroline Codling; Anne-Marie Ceolho; Eamonn M M Quigley; John F Cryan; Timothy G Dinan
Journal:  Biol Psychiatry       Date:  2008-08-23       Impact factor: 13.382

7.  Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

Authors:  D Guyonnet; O Chassany; P Ducrotte; C Picard; M Mouret; C-H Mercier; C Matuchansky
Journal:  Aliment Pharmacol Ther       Date:  2007-08-01       Impact factor: 8.171

8.  Development of intestinal bifidobacteria and lactobacilli in breast-fed neonates.

Authors:  Jinjin Chen; Wei Cai; Yi Feng
Journal:  Clin Nutr       Date:  2007-05-15       Impact factor: 7.324

9.  Intestinal permeability in preterm infants by feeding type: mother's milk versus formula.

Authors:  Sarah N Taylor; Laura A Basile; Myla Ebeling; Carol L Wagner
Journal:  Breastfeed Med       Date:  2009-03       Impact factor: 1.817

Review 10.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059
View more
  238 in total

Review 1.  Control of antiviral immunity by pattern recognition and the microbiome.

Authors:  Iris K Pang; Akiko Iwasaki
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Microbiome of the paranasal sinuses: Update and literature review.

Authors:  Jivianne T Lee; Daniel N Frank; Vijay Ramakrishnan
Journal:  Am J Rhinol Allergy       Date:  2016 Jan-Feb       Impact factor: 2.467

3.  Lactobacillus acidophilus counteracts enteropathogenic E. coli-induced inhibition of butyrate uptake in intestinal epithelial cells.

Authors:  Anoop Kumar; Waddah A Alrefai; Alip Borthakur; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-13       Impact factor: 4.052

4.  The Intestinal Microbiota of Hermetia illucens Larvae Is Affected by Diet and Shows a Diverse Composition in the Different Midgut Regions.

Authors:  Daniele Bruno; Marco Bonelli; Francesca De Filippis; Ilaria Di Lelio; Gianluca Tettamanti; Morena Casartelli; Danilo Ercolini; Silvia Caccia
Journal:  Appl Environ Microbiol       Date:  2019-01-09       Impact factor: 4.792

Review 5.  Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.

Authors:  Franco Scaldaferri; Viviana Gerardi; Francesca Mangiola; Loris Riccardo Lopetuso; Marco Pizzoferrato; Valentina Petito; Alfredo Papa; Jovana Stojanovic; Andrea Poscia; Giovanni Cammarota; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

6.  Lactobacillus acidophilus counteracts inhibition of NHE3 and DRA expression and alleviates diarrheal phenotype in mice infected with Citrobacter rodentium.

Authors:  Anoop Kumar; Arivarasu N Anbazhagan; Hayley Coffing; Ishita Chatterjee; Shubha Priyamvada; Tarunmeet Gujral; Seema Saksena; Ravinder K Gill; Waddah A Alrefai; Alip Borthakur; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-15       Impact factor: 4.052

7.  Probiotic potential of novel Lactobacillus strains isolated from salted-fermented shrimp as antagonists for Vibrio parahaemolyticus.

Authors:  Bao Le; Seung Hwan Yang
Journal:  J Microbiol       Date:  2018-02-02       Impact factor: 3.422

8.  Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Authors:  Zohreh Karbaschian; Zeinab Mokhtari; Abdolreza Pazouki; Ali Kabir; Mahdi Hedayati; Somayeh Soleymanzadeh Moghadam; Parvin Mirmiran; Azita Hekmatdoost
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

9.  Expression of bioactive porcine interferon-alpha in Lactobacillus casei.

Authors:  Shi-jie Ma; Kun Li; Xin-Sheng Li; Xiao-Qing Guo; Peng-Fei Fu; Ming-Fan Yang; Hong-Ying Chen
Journal:  World J Microbiol Biotechnol       Date:  2014-05-13       Impact factor: 3.312

Review 10.  Gut microbiome, gut function, and probiotics: Implications for health.

Authors:  Neerja Hajela; B S Ramakrishna; G Balakrish Nair; Philip Abraham; Sarath Gopalan; Nirmal K Ganguly
Journal:  Indian J Gastroenterol       Date:  2015-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.